Moyamoya Disease: A Cerebrovascular Involvement in a Child with Wiskott–Aldrich Syndrome
Authors:
Open Access
- 1 January 2025
- journal article
- Published by Wolters Kluwer Health in Indian Pediatrics Case Reports
- Vol. 5 (1) , 18-22
Abstract
Background: Wiskott–Aldrich syndrome (WAS) is a rare X-linked disorder characterized by immunodeficiency, thrombocytopenia, and eczema, with a risk of autoimmune phenomena. Clinical Description: A 3-year-old boy presented to us with a history of recurrent skin and mucosal bleeds, itchy skin lesions, and recurrent purulent ear discharge. He had been hospitalized for pneumonia and meningitis earlier, having developed left-sided hemiplegia associated with a cerebral infarct. On examination, he was growth retarded with pallor, hepatosplenomegaly, multiple purpuric spots, and infected scalp lesions. In addition, he had spastic hemiparesis in the left side. Management and Outcome: Investigation revealed microcytic hypochromic anemia, eosinophilia, thrombocytopenia, and very high IgE titer (10,433). Coagulation profile was normal. Tuberculosis work-up was negative. The mean platelet volume was low normal (7.3) and bone marrow showed decreased number and size of megakaryocytes. Exome sequencing showed pathogenic mutation of WAS gene in exon 3 hemizygous XLR variant. The patient received weekly intravenous immunoglobulin therapy and cotrimoxazole. The eczema, thrombocytopenia, and infections improved. Later, he developed sudden-onset bilateral loss of vision. Magnetic resonance (MR) imaging brain revealed acute infarct on the left occipital region and gliosis in the right cerebral hemisphere with MR angiography showing middle and posterior cerebral artery thrombosis and narrowing of bilateral distal internal carotid arteries suggestive of moyamoya disease. Immunosuppressive agents and antiplatelets could not be administered, so the child was kept under supportive care. Conclusion: This case makes pediatricians aware of the possibility of cerebrovascular events as a manifestation of autoimmune vasculitis in children with WAS. Optimal treatment for such cases needs research.Keywords
This publication has 10 references indexed in Scilit:
- Autoimmunity in Wiskott–Aldrich Syndrome: Updated PerspectivesThe Application of Clinical Genetics, 2021
- Wiskott Aldrich Syndrome: A Multi-Institutional Experience From IndiaFrontiers in Immunology, 2021
- A rare case of Wiskott-Aldrich Syndrome with normal platelet size: a case reportJournal of Medical Case Reports, 2016
- Current and emerging treatment options for Wiskott–Aldrich syndromeExpert Review of Clinical Immunology, 2015
- Wiskott‐Aldrich syndrome: a comprehensive reviewAnnals of the New York Academy of Sciences, 2013
- WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and functionBlood, 2008
- Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlationBlood, 2004
- Autoimmunity in Wiskott-Aldrich Syndrome: Risk Factors, Clinical Features, and Outcome in a Single-Center Cohort of 55 PatientsPediatrics, 2003
- Kawasaki Disease in a Patient with Wiskott-Aldrich Syndrome: An Increase in the Platelet CountInternational Journal of Hematology, 2003
- Fatal arteritis as a complication of Wiskott-Aldrich syndromeThe Journal of Pediatrics, 1979